Akut Lenfoblastik Lösemili Çocuklarda İdame Tedavisinin Nadir Bir Komplikasyonu: Folik Asit Eksikliği

Year 2020, Volume: 5 Issue: 4, 701 - 704, 30.12.2020

Mustafa Büyükavcı , Olena Erkun , Ayşegül Pala , Mehmet Fatih Orhan

https://doi.org/10.26453/otjhs.742731

Abstract

Vitamin B12 (cobalamin) and folic acid play a crucial role in DNA synthesis, cell division and proliferation. Their deficiency may cause serious disorders of hematopoietic, gastrointestinal and neurologic system. A 14-year-old girl, undergoing maintenance chemotherapy (methotrexate, 6-mercaptopurine) for acute lymphoblastic leukemia (ALL), presented with the complaints of pallor and nose bleeding. At admission, white blood cells (WBC) was 2230/mm3, hemoglobin 6.2 gr/dL, mean corpuscular volume (MCV) 122 fL and thrombocytes 26700/mm3. Peripheral blood smear revealed hypersegmented neutrophils, macrocytosis, anisocytosis, rare normoblasts and 4-5 platelet per field. Bone marrow aspiration and biopsy did not confirm the pre-diagnoses of relapsed ALL, hemophagocytic lymphohistiocytosis (HLH) and myelodysplastic syndrome (MDS). Vitamin B12 and folic acid were prescribed after obtaining the results of vitamin B12 (587 pg/mL), folic acid (1.3 ng/mL) and homocystein (21 µmol/L). Folic acid deficiency must be kept in mind in childrenwith ALL receiving maintenance therapy. Serum cobalamin and folic acid levels must be checked in case of unexplained pancytopenia.

Keywords

Anemi, Folik asit, lösemi, Pansitopeni

A Rare Complication of Maintenance Therapy in Children with Acute Lymphoblastic Leukemia: Folic Acid Deficiency

Abstract

Vitamin B12 (cobalamin) and folic acid play a crucial role in DNA synthesis, cell division and proliferation. Their deficiency may cause serious disorders of hematopoietic, gastrointestinal and neurologic system. A 14-year-old girl, undergoing maintenance chemotherapy (methotrexate, 6-mercaptopurine) for acute lymphoblastic leukemia (ALL), presented with the complaints of pallor and nose bleeding. At admission, white blood cells (WBC) was 2230/mm3, hemoglobin 6.2 gr/dL, mean corpuscular volume (MCV) 122 fL and thrombocytes 26700/mm3. Peripheral blood smear revealed hypersegmented neutrophils, macrocytosis, anisocytosis, rare normoblasts and 4-5 platelet per field. Bone marrow aspiration and biopsy did not confirm the pre-diagnoses of relapsed ALL, hemophagocytic lymphohistiocytosis (HLH) and myelodysplastic syndrome (MDS). Vitamin B12 and folic acid were prescribed after obtaining the results of vitamin B12 (587 pg/mL), folic acid (1.3 ng/mL) and homocystein (21 µmol/L). Folic acid deficiency must be kept in mind in childrenwith ALL receiving maintenance therapy. Serum cobalamin and folic acid levels must be checked in case of unexplained pancytopenia.

Keywords

Anemia, pancytopenia, folic acid, leukemia

References

• 1U.S. National Institutes of Health. Vitamin B12. 2020.https://ods.od.nih.gov/factsheets/VitaminB12HealthProfessional/. Erişim tarihi 29 Haziran 2020.
• Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 2017;129(19):2603-2611.
• Qiu A, Jansen M, Sakaris A, et al. Identification of an Intestinal Folate Transporter and the Molecular Basis for Hereditary Folate Malabsorption. Cell. 2006;127(5):917-928.
• Roy Moulik N, Kumar A, Agrawal S, Mahdi AA. Folate deficiency in north Indian children undergoing maintenance chemotherapy for acute lymphoblastic leukemia-Implications and outcome. Pediatr Blood Cancer. 2018;65(1). doi:10.1002/pbc.26730
• Socha DS, DeSouza SI, Flagg A, Sekeres M, Rogers HJ. Severe megaloblastic anemia: Vitamin deficiency and other causes. Cleve Clin J Med. 2020;87(3):153-164.
• Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496-513.
• Lanzkowsky P. Chapter 7 -Megaloblastic Anemia. In: Lanzkowsky P, Lipton JM, Fish JD, Editors Lanzkowsky's Manual of Pediatric Hematology and Oncology. 6th Edition. Academic Press: San Diego. 2016:32-41.
• Robien K. Folate during antifolate chemotherapy: what we know... and do not know. Nutr Clin Pract. 2005;20(4):411-422.
• Schrøder H, Clausen N, Ostergård E, Pressler T. Folic acid supplements in vitamin tablets: a determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1986;3(3):241-247.
• Kennedy DA, Grupp S, Greenberg M, Koren G. Folate fortification and survival ofchildren with acute lymphoblastic leukemia. Pediatr Drugs. 2011;1;13(3):193-196.